Filter News
Area of Research
- (-) Isotopes (4)
- (-) Supercomputing (12)
- Biological Systems (1)
- Biology and Environment (15)
- Clean Energy (10)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (5)
- Fusion Energy (1)
- Materials (7)
- Materials for Computing (1)
- National Security (3)
- Neutron Science (9)
- Nuclear Science and Technology (7)
News Topics
- (-) Biomedical (16)
- 3-D Printing/Advanced Manufacturing (5)
- Artificial Intelligence (33)
- Big Data (14)
- Bioenergy (9)
- Biology (10)
- Biotechnology (2)
- Buildings (3)
- Chemical Sciences (4)
- Climate Change (16)
- Computer Science (76)
- Coronavirus (12)
- Cybersecurity (8)
- Decarbonization (4)
- Energy Storage (6)
- Environment (17)
- Exascale Computing (19)
- Frontier (25)
- Grid (4)
- High-Performance Computing (31)
- Isotopes (22)
- Machine Learning (12)
- Materials (15)
- Materials Science (15)
- Mathematics (1)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (10)
- National Security (9)
- Net Zero (1)
- Neutron Science (13)
- Nuclear Energy (6)
- Partnerships (1)
- Physics (7)
- Quantum Computing (15)
- Quantum Science (20)
- Security (5)
- Simulation (11)
- Software (1)
- Space Exploration (4)
- Summit (35)
- Sustainable Energy (8)
- Transportation (5)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.